Overview
Actuated Medical's NeuralGlider(r) Precision Brain Access Platform has been scientifically validated by more than 40 preclinical neuroscience research groups worldwide and cited in over 44 peer-reviewed publications. Actuated is now optimizing NeuralGlider for clinical applications to improve access to deep brain targets while reducing tissue disruption in delicate brain structures. The company is partnering with organizations seeking to improve the insertion precision of neuromodulation systems, gene therapies, brain-computer interfaces, and other next-generation neurotechnologies.
More in Neurotechnology
Latest industry news
Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%
2026-09-02 · Industry
Merge Labs and Butterfly Network Unite to Push Ultrasound-Based BCIs Into the Mainstream
2026-09-01 · Industry
FDA Grants CorTec Second Breakthrough Device Designation for Its Brain-Computer Interface
2026-08-31 · Policy
Aurenar Raises $5.7M to Bring Stroke Neuromodulation to the Recovery Room
2026-08-30 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →